Clinical trial
A Prospective, Randomized, Double-blind, Multicenter Study on the Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)
NCT04707261 is registered in ClinicalTrials.gov with Xiangtan Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Double-blind, Multicenter Study on the Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)
- Lead sponsor
- Xiangtan Central Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 6, 2021
- Completion date
- January 1, 2026
- Enrollment
- 1,990 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.